Search research articles
Contact Us
Filters
Showing results (91-100 of 116) with videos related to
Page
of 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2023
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes
Ryan A Denu, Richard K Yang, Alexander J Lazar, et al.
Oncotarget
|
September 3, 2016
Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy
Haeseong Park, Ignacio Garrido-Laguna, Aung Naing, et al.
Cancer Medicine
|
September 24, 2022
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma
Prapassorn Thirasastr, Heather Lin, Behrang Amini, et al.
JAMA Oncology
|
May 1, 2018
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib
Scott M Schuetze, Vanessa Bolejack, Dafydd G Thomas, et al.
Journal of Hematology & Oncology
|
June 12, 2015
STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion
Vivek Subbiah, Caitlin McMahon, Shreyaskumar Patel, et al.
Cancers
|
March 13, 2024
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?
Prapassorn Thirasastr, Thomas L Sutton, Cissimol P Joseph, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2021
Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study
Yoon-Koo Kang, Suzanne George, Robin L Jones, et al.
The Oncologist
|
July 30, 2017
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma
Silvia Stacchiotti, Olivier Mir, Axel Le Cesne, et al.
Cancers
|
May 11, 2024
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience
Lewis F Nasr, Marianne Zoghbi, Rossana Lazcano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2022
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)
Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 116) with videos related to
Sort By:
Page
of 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2023
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes
Ryan A Denu, Richard K Yang, Alexander J Lazar, et al.
Oncotarget
|
September 3, 2016
Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy
Haeseong Park, Ignacio Garrido-Laguna, Aung Naing, et al.
Cancer Medicine
|
September 24, 2022
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma
Prapassorn Thirasastr, Heather Lin, Behrang Amini, et al.
JAMA Oncology
|
May 1, 2018
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib
Scott M Schuetze, Vanessa Bolejack, Dafydd G Thomas, et al.
Journal of Hematology & Oncology
|
June 12, 2015
STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion
Vivek Subbiah, Caitlin McMahon, Shreyaskumar Patel, et al.
Cancers
|
March 13, 2024
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?
Prapassorn Thirasastr, Thomas L Sutton, Cissimol P Joseph, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2021
Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study
Yoon-Koo Kang, Suzanne George, Robin L Jones, et al.
The Oncologist
|
July 30, 2017
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma
Silvia Stacchiotti, Olivier Mir, Axel Le Cesne, et al.
Cancers
|
May 11, 2024
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience
Lewis F Nasr, Marianne Zoghbi, Rossana Lazcano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2022
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)
Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik, et al.
Page
of 12